Takeda Pharmaceutical TAK
NYSE TAK
$17.87 -0.32 (-1.76%)
As of: Oct 1, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Goodwill impairment charges (2019)

Updated

Takeda Pharmaceutical (TAK) recorded Goodwill impairment charges of $47.25 million in the quarter ended Mar 31, 2019.

Analysis

Takeda Pharmaceutical (TAK) Goodwill impairment charges (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Takeda Pharmaceutical 2.63 Bn -23.88 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 47.25 Mn
API Access

Takeda Pharmaceutical Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=TAK&period=max&api_key=YOUR_API_KEY